CJC-1295 + Ipamorelin
A co-formulated research blend pairing a GHRH analogue with a selective ghrelin-receptor agonist.
View in catalog →Overview
This is a combination of two secretagogues that act on complementary pathways — CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin-receptor agonist). The pairing is a common research design because the two mechanisms are studied together for their combined effect on growth-hormone release.
How it’s studied to work
CJC-1295 engages the GHRH receptor while Ipamorelin engages the ghrelin (GHS-R1a) receptor. Because these are separate upstream inputs to the same pituitary output, they are frequently studied in combination.
Research areas
- ›Combined secretagogue pharmacology
- ›Growth-hormone / IGF-1 axis research
Handling & storage
- Storage
- Lyophilized; store cold, long-term at −20 °C.
- Reconstitution
- Bacteriostatic water for laboratory reconstitution.
Further reading
Links open external literature databases. Citations are curated starting points, not an exhaustive or endorsing list.
For laboratory and research use only. Not a drug, supplement, or medical device. This page is educational and is not medical advice; nothing here describes a product intended for human or veterinary use.